Evidence map›Paper›PMID 32616891›Full record

ReviewOncogene2020

Pathomechanisms in schwannoma development and progression.

Dario-Lucas Helbing, Alexander Schulz, Helen Morrison

Abstract readReview
In one paragraph

Review in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Fimepinostat Promotes Apoptosis and Decreases Cytokine Secretion inInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Gallbladder Schwannoma: A Case Report and Literature Review.Diagnostics (Basel, Switzerland) · 2025
    Article
  14. Breast schwannoma: review of entity and differential diagnosis.Journal of pathology and translational medicine · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Optic nerve sheath schwannoma: illustrative case.Journal of neurosurgery. Case lessons · 2025
    Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Dario-Lucas HelbingLeibniz Institute on Aging, Fritz Lipmann Institute, 07745, Jena, Germany.
Alexander SchulzLeibniz Institute on Aging, Fritz Lipmann Institute, 07745, Jena, Germany.
Helen MorrisonLeibniz Institute on Aging, Fritz Lipmann Institute, 07745, Jena, Germany. Helen.Morrison@leibniz-fli.de.ORCID http://orcid.org/0000-0003-4938-1409

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schwannomas are tumors of the peripheral nervous system, consisting of different cell types. These include tumorigenic Schwann cells, axons, macrophages, T cells, fibroblasts, blood vessels, and an extracellular matrix. All cell types involved constitute an intricate "tumor microenvironment" and play relevant roles in the development and progression of schwannomas. Although Nf2 tumor suppressor gene-deficient Schwann cells are the primary tumorigenic element and principle focus of current research efforts, evidence is accumulating regarding the contributory roles of other cell types in schwannoma pathology. In this review, we aim to provide an overview of intra- and intercellular mechanisms contributing to schwannoma formation. "Genes load the gun, environment pulls the trigger." -George A. Bray.

Indexed as

AnimalsDisease ProgressionHumansMiceNeurilemmoma

Identifiers

PMID32616891
PMCPMC7410823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.